Three-arm Phase III Trial Comparing Radiotherapy With Different Chemotherapy Regimens for Esophageal Cancer
Latest Information Update: 13 Feb 2023
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CRTCOESC
- 03 Feb 2023 Planned number of patients changed from 630 to 249.
- 03 Feb 2023 Planned End Date changed from 25 Apr 2022 to 1 Apr 2025.
- 22 Jan 2022 Results presented at the 2022 Gastrointestinal Cancers Symposium